SQZ BIOTECHNOLOGIES COMPANY Increase (Decrease) in Deferred Revenue
SQZ BIOTECHNOLOGIES COMPANY reported Increase (Decrease) in Deferred Revenue of -$715.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2023-11-08
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in deferred revenue for the quarter ending 2023-09-30 was -$500.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in deferred revenue for the quarter ending 2023-06-30 was -$178.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in deferred revenue for the quarter ending 2023-03-31 was -$37.00K.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in deferred revenue for the quarter ending 2022-12-31 was -$11.98M.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in deferred revenue for fiscal 2022 was -$20.99M.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in deferred revenue for fiscal 2021 was -$23.87M, a 602.80% decline from fiscal 2020.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in deferred revenue for fiscal 2020 was $4.75M.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in deferred revenue for fiscal 2019 was -$4.89M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$678.00K derived: sum of 2 quarters · filed 2023-11-08 | -$715.00K 10-Q · filed 2023-11-08 | -$12.70M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | -$178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$215.00K 10-Q · filed 2023-08-10 | -$12.20M derived: sum of 3 quarters · filed 2023-08-10 | -$15.33M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-03-31 | -$37.00K 10-Q · filed 2023-05-10 | -$12.02M derived: sum of 2 quarters · filed 2023-05-10 | -$15.15M derived: sum of 3 quarters · filed 2023-11-08 | -$18.16M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-12-31 | -$11.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$15.11M derived: sum of 2 quarters · filed 2023-11-08 | -$18.12M derived: sum of 3 quarters · filed 2023-11-08 | -$20.99M 10-K · filed 2023-03-22 |
| 2022-09-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$6.14M derived: sum of 2 quarters · filed 2023-11-08 | -$9.01M 10-Q · filed 2023-11-08 | -$18.36M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$5.88M 10-Q · filed 2023-08-10 | -$15.23M derived: sum of 3 quarters · filed 2023-08-10 | -$19.98M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$2.87M 10-Q · filed 2023-05-10 | -$12.22M derived: sum of 2 quarters · filed 2023-05-10 | -$16.98M derived: sum of 3 quarters · filed 2023-05-10 | -$21.29M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$9.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$14.11M derived: sum of 2 quarters · filed 2023-03-22 | -$18.42M derived: sum of 3 quarters · filed 2023-03-22 | -$23.87M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$4.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$9.07M derived: sum of 2 quarters · filed 2022-11-09 | -$14.52M 10-Q · filed 2022-11-09 | -$17.01M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$9.77M 10-Q · filed 2022-08-04 | -$12.26M derived: sum of 3 quarters · filed 2022-08-04 | -$16.48M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$5.45M 10-Q · filed 2022-05-10 | -$7.94M derived: sum of 2 quarters · filed 2022-05-10 | -$12.17M derived: sum of 3 quarters · filed 2022-05-10 | -$16.31M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | -$6.72M derived: sum of 2 quarters · filed 2022-03-16 | -$10.86M derived: sum of 3 quarters · filed 2022-03-16 | $4.75M 10-K · filed 2022-03-16 |
| 2020-09-30 | -$4.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$8.37M derived: sum of 2 quarters · filed 2021-11-10 | $7.24M 10-Q · filed 2021-11-10 | $1.74M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$4.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $11.46M 10-Q · filed 2021-08-04 | $5.96M derived: sum of 3 quarters · filed 2021-08-04 | |
| 2020-03-31 | $15.61M 10-Q · filed 2021-05-11 | $10.11M derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | -$5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$4.89M 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $606.00K 10-Q · filed 2020-12-10 |